Utter Garth H, Lee Tzong-Hae, Rivers Ryan M, Montalvo Lani, Wen Li, Chafets Daniel M, Reed William F, Busch Michael P
Department of Surgery, University of California, Davis, Medical Center, Sacramento, California 95817, USA.
Transfusion. 2008 Aug;48(8):1609-15. doi: 10.1111/j.1537-2995.2008.01758.x. Epub 2008 May 22.
Blood transfusion after traumatic injury can result in microchimerism (MC) of donor white cells (WBCs) in the recipient as late as 2 to 3 years postinjury, the longest prospective follow-up to date. The purpose of this study was to determine how long transfusion-associated MC lasts after traumatic injury.
A group of US combat veterans who received transfusions who responded to a recruitment notice was retrospectively evaluated. Their blood was sampled, and MC was assessed by quantitative allele-specific polymerase chain reaction detection of differences at the HLA-DR locus or a panel of insertion-deletion polymorphism loci. Results of veterans were compared to those from an age- and gender-matched blood donor control group, from whom WBCs were retrieved from leukoreduction filters.
Among 163 combat veterans who received transfusion and 150 control subjects who did not receive transfusions, 16 (9.8%) of the veterans and 1 (0.7%) control subject had evidence of MC (relative risk, 14.7; 95% confidence interval, 2.0-110). The veterans with MC included 3 who served in WWII (7% of subjects from that conflict), 5 in Korea (18%), and 6 in Vietnam (7%).
Transfusion for combat-related injury can result in MC that lasts for 60 years, suggesting that it may involve permanent engraftment. MC is rare among male blood donors who did not receive transfusions, who are probably representative of individuals who have not had postnatal allogeneic exposures.
创伤性损伤后输血可导致受者体内供体白细胞微嵌合体(MC),这种情况在受伤后2至3年仍可出现,这是迄今为止最长的前瞻性随访研究。本研究的目的是确定创伤性损伤后输血相关的微嵌合体持续多长时间。
对一组因应招募通知而接受输血的美国退伍军人进行回顾性评估。采集他们的血液样本,通过定量等位基因特异性聚合酶链反应检测HLA - DR位点或一组插入缺失多态性位点的差异来评估微嵌合体。将退伍军人的结果与年龄和性别匹配的献血者对照组的结果进行比较,从白细胞滤除器中获取该对照组的白细胞。
在163名接受输血的退伍军人和150名未接受输血的对照受试者中,16名(9.8%)退伍军人和1名(0.7%)对照受试者有微嵌合体证据(相对风险为14.7;95%置信区间为2.0 - 110)。有微嵌合体的退伍军人中,3人曾参加二战(占该冲突中受试者的7%),5人参加过朝鲜战争(18%),6人参加过越南战争(7%)。
因战斗相关损伤而输血可导致微嵌合体持续60年,这表明可能涉及永久性植入。在未接受输血的男性献血者中微嵌合体很少见,这些献血者可能代表了未经历过产后异体暴露的个体。